ID

12870

Beschreibung

Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00942318

Link

https://clinicaltrials.gov/show/NCT00942318

Stichworte

  1. 04.01.16 04.01.16 -
Hochgeladen am

4. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Type 2 Diabetes Mellitus NCT00942318

Eligibility Type 2 Diabetes Mellitus NCT00942318

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus
Beschreibung

diabetes mellitus type 2

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
age > 18 years
Beschreibung

ID.2

Datentyp

boolean

patients treated for at least 6 months by multiple daily insulin injections associating long acting insulin (at least 1 long acting insulin analog injection-glargine or detemir- or at least 2 nph insulin injections) plus mealtimes rapid acting insulin injections (human or analogs) +/- oral hypoglycemic agents.
Beschreibung

long acting insulin; rapid acting insulin

Datentyp

boolean

Alias
UMLS CUI [1]
C0304870
UMLS CUI [2]
C0356365
7,5% ≤ hba1c ≤ 10%
Beschreibung

hba1c

Datentyp

boolean

Alias
UMLS CUI [1]
C0019018
patients able to perform self-monitoring blood glucose (smbg) measurement and insulin injections.
Beschreibung

Blood Glucose Self-Monitoring

Datentyp

boolean

Alias
UMLS CUI [1]
C0005803
smbg > 3/day
Beschreibung

Blood Glucose Self-Monitoring

Datentyp

boolean

Alias
UMLS CUI [1]
C0005803
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
diabetic retinopathy contraindicating glycemic control intensification
Beschreibung

diabetic retinopathy

Datentyp

boolean

Alias
UMLS CUI [1]
C0011884
situation or pathology not allowing therapeutic education program (blindness, deafness, low language fluency…)
Beschreibung

Comorbidity Limited Compliance behavior

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C1321605
situation or pathology not allowing insulin therapy self-management and / or portable insulin pump use (rheumatologic pathology, low visual acuity, …)
Beschreibung

Comorbidity Limited Compliance behavior

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C1321605
recent (<3 month) serious pathology
Beschreibung

pathology

Datentyp

boolean

Alias
UMLS CUI [1]
C0030664
planned treatment or therapy able to induce long-term glycemic control worsening
Beschreibung

Poor glycemic control

Datentyp

boolean

Alias
UMLS CUI [1]
C0342299
long lasting (> 2 month) planned treatment with glucocorticoids, octreotide, lanreotide or danazol
Beschreibung

glucocorticoids; octreotide

Datentyp

boolean

Alias
UMLS CUI [1]
C0017710
UMLS CUI [2]
C0028833
pregnancy wish or ongoing pregnancy
Beschreibung

pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0549206
known haemoglobinopathy.
Beschreibung

haemoglobinopathy

Datentyp

boolean

Alias
UMLS CUI [1]
C0019045
creatinin clearance <30ml/min (mdrd formula).
Beschreibung

creatinin clearance

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
organ transplant.
Beschreibung

organ transplant

Datentyp

boolean

Alias
UMLS CUI [1]
C0029216

Ähnliche Modelle

Eligibility Type 2 Diabetes Mellitus NCT00942318

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
diabetes mellitus type 2
Item
type 2 diabetes mellitus
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
ID.2
Item
age > 18 years
boolean
long acting insulin; rapid acting insulin
Item
patients treated for at least 6 months by multiple daily insulin injections associating long acting insulin (at least 1 long acting insulin analog injection-glargine or detemir- or at least 2 nph insulin injections) plus mealtimes rapid acting insulin injections (human or analogs) +/- oral hypoglycemic agents.
boolean
C0304870 (UMLS CUI [1])
C0356365 (UMLS CUI [2])
hba1c
Item
7,5% ≤ hba1c ≤ 10%
boolean
C0019018 (UMLS CUI [1])
Blood Glucose Self-Monitoring
Item
patients able to perform self-monitoring blood glucose (smbg) measurement and insulin injections.
boolean
C0005803 (UMLS CUI [1])
Blood Glucose Self-Monitoring
Item
smbg > 3/day
boolean
C0005803 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
diabetic retinopathy
Item
diabetic retinopathy contraindicating glycemic control intensification
boolean
C0011884 (UMLS CUI [1])
Comorbidity Limited Compliance behavior
Item
situation or pathology not allowing therapeutic education program (blindness, deafness, low language fluency…)
boolean
C0009488 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
Comorbidity Limited Compliance behavior
Item
situation or pathology not allowing insulin therapy self-management and / or portable insulin pump use (rheumatologic pathology, low visual acuity, …)
boolean
C0009488 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
pathology
Item
recent (<3 month) serious pathology
boolean
C0030664 (UMLS CUI [1])
Poor glycemic control
Item
planned treatment or therapy able to induce long-term glycemic control worsening
boolean
C0342299 (UMLS CUI [1])
glucocorticoids; octreotide
Item
long lasting (> 2 month) planned treatment with glucocorticoids, octreotide, lanreotide or danazol
boolean
C0017710 (UMLS CUI [1])
C0028833 (UMLS CUI [2])
pregnancy
Item
pregnancy wish or ongoing pregnancy
boolean
C0549206 (UMLS CUI [1])
haemoglobinopathy
Item
known haemoglobinopathy.
boolean
C0019045 (UMLS CUI [1])
creatinin clearance
Item
creatinin clearance <30ml/min (mdrd formula).
boolean
C0201976 (UMLS CUI [1])
organ transplant
Item
organ transplant.
boolean
C0029216 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video